Treatment with poly- and monoclonal antilymphocyte antibodies: assessment of efficacy and safety in transplantation

Transplant Proc. 1992 Feb;24(1):314.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use*
  • Follow-Up Studies
  • Graft Rejection
  • Humans
  • Kidney Transplantation / immunology*
  • Middle Aged
  • Muromonab-CD3 / adverse effects
  • Muromonab-CD3 / therapeutic use*
  • Retrospective Studies

Substances

  • Antilymphocyte Serum
  • Muromonab-CD3